What do we know about Mazdutide, the medication with which you can lose up to 20 kilograms in a year?
Mazdutide, a weight-loss medication, shows significant weight loss results in a Chinese study, with participants losing an average of nearly 19% of their body weight over 48 weeks.
Fiocruz starts studies with therapy for Spinal Muscular Atrophy; costs may reach 25% of current value
Fiocruz has initiated its first clinical study for a gene therapy aimed at treating severe Spinal Muscular Atrophy (SMA) in Brazil, potentially reducing treatment costs significantly.
Ayahuasca psychedelic DMT shows promise as depression therapy
A study indicates that DMT, a key component of the psychedelic ayahuasca, may effectively reduce depression symptoms in patients.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
Novo on the way with a new weight loss drug
Novo Nordisk has released data from a study on a weight loss drug developed in collaboration with Chinese company United Biotechnology, showing significant weight loss among participants.
Colon Cancer: A Study Confirmed That Early Detection Reduces Cases of Severity
A clinical study shows that screening for colorectal cancer significantly aids early detection and reduces advanced cases.
Men addicted to sex, pornography, and compulsive masturbation – this study is for you
A groundbreaking clinical trial in Poland is set to examine the pharmacological treatment of compulsive sexual behaviors, particularly focusing on compulsive masturbation.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Know the risks of retatrutida, a weight loss pen still in study phase
The article discusses the risks associated with the use of retatrutida, a weight loss pen not yet approved for use in any country and currently under clinical study.
Single dose of powerful psychedelic cuts depression symptoms in clinical study
A clinical study demonstrates that a single dose of the psychedelic DMT significantly alleviates symptoms of major depressive disorder compared to a placebo.